Cyclacel Pharmaceuticals (CYCC) Earnings Date, Estimates & Call Transcripts $0.37 -0.02 (-4.91%) (As of 11/15/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cyclacel Pharmaceuticals Latest Earnings SummaryUpcoming Earnings DateMar. 18EstimatedActual EPS (Nov. 12) -$0.18 Beat By $0.36 Consensus EPS (Nov. 12) -$0.54 Cyclacel Pharmaceuticals released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.18, which beat analysts' consensus estimates of -$0.54 by $0.36. Quarterly revenue was reported to be $0.01 million, below analyst estimates of $0.01 million. With a trailing EPS of -$9.40, Cyclacel Pharmaceuticals' earnings are expected to grow next year, from ($1.95) to ($1.18) per share. CYCC Upcoming EarningsCyclacel Pharmaceuticals' next earnings date is estimated for Tuesday, March 18, 2025, based off prior year's reporting schedules. Get Cyclacel Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cyclacel Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCYCC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CYCC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the Markets📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> Cyclacel Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241-$0.83-$0.83-$0.83Q3 20241-$0.54-$0.54-$0.54Q4 20241-$0.29-$0.29-$0.2920243-$1.66-$1.66-$1.66Q1 20251-$0.29-$0.29-$0.29Q2 20251-$0.30-$0.30-$0.30Q3 20251-$0.30-$0.30-$0.30Q4 20251-$0.30-$0.30-$0.30FY 20254($1.19)($1.19)($1.19) Cyclacel Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 3/18/2025(Estimated)------- 11/12/2024--$0.54-$0.18+$0.36-$0.18$0.01M$0.01M8/14/2024Q2 2024-$0.83-$0.72+$0.11-$0.72$0.03M- 5/14/2024Q1 2024-$4.93-$2.27+$2.66-$2.27-$0.03M 3/19/2024Q4 2023-$6.35-$6.23+$0.12-$6.23-$0.03M11/13/2023Q3 2023-$5.70-$7.35 -$1.65-$0.49-$0.02M8/9/2023Q2 2023-$8.10-$6.60+$1.50-$0.44-$0.37M Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023-$10.20-$7.05+$3.15-$0.47--3/6/2023Q4 2022-$7.20-$9.00 -$1.80-$0.60-- Cyclacel Pharmaceuticals Earnings - Frequently Asked Questions When is Cyclacel Pharmaceuticals's earnings date? Cyclacel Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 18th, 2025 based off last year's report dates. Learn more on CYCC's earnings history. Did Cyclacel Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported ($0.18) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.54) by $0.36. Learn more on analysts' earnings estimate vs. CYCC's actual earnings. How much revenue does Cyclacel Pharmaceuticals generate each year? Cyclacel Pharmaceuticals (NASDAQ:CYCC) has a recorded annual revenue of $420,000.00. How much profit does Cyclacel Pharmaceuticals generate each year? Cyclacel Pharmaceuticals (NASDAQ:CYCC) has a recorded net income of -$22.56 million. CYCC has generated -$9.40 earnings per share over the last four quarters. What is Cyclacel Pharmaceuticals's EPS forecast for next year? Cyclacel Pharmaceuticals's earnings are expected to grow from ($1.95) per share to ($1.18) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies China Pharma Earnings Pasithea Therapeutics Earnings Processa Pharmaceuticals Earnings Gritstone bio Earnings Shuttle Pharmaceuticals Earnings Avalon GloboCare Earnings InMed Pharmaceuticals Earnings Mainz Biomed Earnings Sunshine Biopharma Earnings Palisade Bio Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for Investors 📉 Warning: Market Crash Predicted - Secure Your Savings (Ad)The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> This page (NASDAQ:CYCC) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYCC Stock Alerts